title: [Dipyridamole plus acetylsalicylic acid--who is to be trusted?].
authors.forename: T P
authors.initials: TP
authors.lastname: Almdal
authors.forename: E
authors.initials: E
authors.lastname: Eldrup
authors.forename: J
authors.initials: J
authors.lastname: Godtfredsen
authors.forename: A
authors.initials: A
authors.lastname: Kofoed-Enevoldsen
mesh_terms: D001241:Aspirin / Q000008:administration & dosage* / Q000009:adverse effects; D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D004176:Dipyridamole / Q000008:administration & dosage* / Q000009:adverse effects; D004359:Drug Therapy, Combination; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D016032:Randomized Controlled Trials as Topic; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D014665:Vasodilator Agents; D004176:Dipyridamole; D001241:Aspirin